![]() |
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 13, Issue 6, 1846-1856, June 2002






The major histocompatibility complex class II associated invariant
chain (Ii) has been shown to inhibit endocytic transport and to
increase the size of endosomes. We have recently found that this
property has a significant impact on antigen processing and
presentation. Here, we show in a cell-free endosome fusion assay that
expression of Ii can increase fusion after phosphatidylinositol 3-kinase activity is blocked by wortmannin. In live cells wortmannin was also not able to block formation of the Ii-induced enlarged endosomes. The effects of Ii on endosomal transport and morphology depend on elements within the cytoplasmic tail. Data from mutagenesis analysis and nuclear magnetic resonance-based structure calculations of
the Ii cytoplasmic tail demonstrate that free negative charges that are
not involved in internal salt bridges are essential for both
interactions between the tails and for the formation of enlarged endosomes. This correlation indicates that it is interactions between
the Ii cytoplasmic tails that are involved in endosome fusion. The
combined data from live cells, cell-free assays, and molecular dynamic
simulations suggest that Ii molecules on different vesicles can promote
endosome docking and fusion and thereby control endosomal traffic of
membrane proteins and endosomal content.
Division of Molecular Cell Biology, Department of
Biology, University of Oslo, 0316 Oslo, Norway; *Centre
d'Immunologie de Marseille-Luminy, Centre National de la Recherche
Scientifique-INSERM-Univ-Med, 13288 Marseille, Cedex 09, France; and
§Istituto di Chimica Biomolecolare del Consiglio Nazionale
delle Ricerche, Comprensorio Olivetti, I-80078 Pozzuoli (Napoli), Italy
The authors have contributed equally to
this work.
Corresponding author. E-mail address:
oddmund.bakke{at}bio.uio.no.
This article has been cited by other articles:
![]() |
C. Beers, A. Burich, M. J. Kleijmeer, J. M. Griffith, P. Wong, and A. Y. Rudensky Cathepsin S Controls MHC Class II-Mediated Antigen Presentation by Epithelial Cells In Vivo J. Immunol., February 1, 2005; 174(3): 1205 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. Gregers, B. Fleckenstein, F. Vartdal, P. Roepstorff, O. Bakke, and I. Sandlie MHC class II loading of high or low affinity peptides directed by Ii/peptide fusion constructs: implications for T cell activation Int. Immunol., November 1, 2003; 15(11): 1291 - 1299. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. C. Ikonomov, D. Sbrissa, M. Foti, J.-L. Carpentier, and A. Shisheva PIKfyve Controls Fluid Phase Endocytosis but Not Recycling/Degradation of Endocytosed Receptors or Sorting of Procathepsin D by Regulating Multivesicular Body Morphogenesis Mol. Biol. Cell, November 1, 2003; 14(11): 4581 - 4591. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Khalil, A. Brunet, I. Saba, R. Terra, R. P. Sekaly, and J. Thibodeau The MHC class II {beta} chain cytoplasmic tail overcomes the invariant chain p35-encoded endoplasmic reticulum retention signal Int. Immunol., October 1, 2003; 15(10): 1249 - 1263. [Abstract] [Full Text] [PDF] |
||||